NuVasive®, Inc.
A
A

Executive Leadership

Gregory T. Lucier, Chairman of the Board and Chief Executive Officer

Gregory T. Lucier

Chairman of the Board and Chief Executive Officer

Gregory T. Lucier has served as our Chairman and Chief Executive Officer since May 2015. He has served as a member of the NuVasive Board of Directors since December 2013.  An established strategic thought leader and business executive in the Life Sciences, Medical Device and Healthcare Technology sectors, Mr. Lucier is a proven game-changer with an eye for innovative technologies that will radically alter healthcare in the 21st century.

Known for his success in the capacity of Chief Executive Officer and in Board Director roles, he has demonstrated expertise in guiding enterprise growth through his focus on the integration of internal operating assets, building innovation capabilities, making accretive acquisitions, creating IP portfolios, expanding globally, and repositioning business models.

As Chairman and CEO of NuVasive, a medical device company that has transformed spine surgery by pioneering minimally invasive, lateral approach spine surgery. Mr. Lucier and his team are again pushing the boundaries of medical device innovation with their recently launched, game-changing Integrated Global Alignment™ procedural solution, poised change, yet again, how spine surgery is done.

Mr. Lucier’s vision on the power of genomics to eradicate disease states, such as cancer, led the growth trajectory of Life Technologies Corporation during the eleven years he served as Chairman and CEO.

The company was at the forefront genomics research, providing more than 50,000 laboratory and genomic testing products to customers in 180 countries, holding over 5,000 essential patents, with $4 billion in revenue to the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion – one of the largest Life Sciences acquisitions to date.  Mr. Lucier’s career with General Electric was focused on starting up and transforming major business models. During his tenure he served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of $1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company’s $2 billion healthcare services business where he successfully led the transformation from a machine maintenance focus to GE being regarded as a powerhouse remote diagnostics.

Mr. Lucier received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.  In addition to serving on the Board of NuVasive, he is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc.  Additionally, Mr. Lucier is a former Chairman of the Board of Life Technologies and director of CareFusion Corporation, now part of Becton, Dickinson & Co.

Patrick Miles, President and Chief Operating Officer

Patrick Miles

President and Chief Operating Officer

Patrick Miles has served as our President and Chief Operating Officer since February 2015 and is responsible for leadership and management of NuVasive’s global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering.  Prior to that, he served as our President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, as our Senior Vice President of Marketing from December 2004 to January 2007, and as our Vice President, Marketing from January 2001 to December 2004. Mr. Miles has more than 20 years of experience in the orthopaedic industry. He served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek. Prior to that, he held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Matt Link,  President,  U.S. Commercial

Matt Link

President, U.S. Commercial

Matt Link has served as our President, U.S. Commercial since July 2015 and is responsible for driving greater sales force efficiencies and the further development of NuVasive’s commercial strategies, including broad efforts to integrate the Company’s sales, service and specialized customer marketing programs.  Previously, he served as our President, U.S. Sales and Service responsible for the leadership of all U.S. field personnel under NuVasive’s combined sales and service organization structure, which includes the management of the Company’s field sales, clinical associates, neurophysiologists and monitoring contracting. Prior to that, Mr. Link served as our Executive Vice President of U.S. Sales from January 2013 to January 2015 and Senior Vice President of Sales for the Company’s U.S. Eastern region from January 2012 to December 2012. Mr. Link joined NuVasive in 2006 and has more than 12 years in the healthcare industry serving in several regional sales positions with DePuy Orthopedics and DePuy Spine. Mr. Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia.

Quentin Blackford, Executive Vice President and Chief Financial Officer

Quentin Blackford

Executive Vice President and Chief Financial Officer

Quentin Blackford has served as our Chief Financial Officer since August 2014. Prior to that he served as Executive Vice President of Finance and Investor Relations since July 2012, and previously served as Vice President, Finance from January 2011.  Mr. Blackford joined NuVasive in 2009 as our Corporate Controller and has more than 10 years of experience in the healthcare industry, including his time at Zimmer Holdings, Inc. where he held various roles and responsibilities, including the Director of Finance & Controller for Zimmer’s Dental Division where he was responsible for all finance, accounting and IT activities for the worldwide division.  Prior to that he was responsible for the global corporate financial planning and analysis function.  Mr. Blackford is a Certified Public Accountant and obtained Bachelor of Science degrees in both Accounting and Business Administration from Grace College.

Jason M. Hannon, Executive Vice President, International

Jason M. Hannon

Executive Vice President, International

Jason M. Hannon has served as our Executive Vice President, International since July 2015 and is responsible for NuVasive’s business and commercial operations outside of the United States, including leading the Company’s international expansion opportunities. Prior to that, Mr. Hannon served as NuVasive’s Executive Vice President, Corporate Development and General Counsel since January 2010 and previously was our Senior Vice President, Corporate Development and General Counsel. He has been with NuVasive since 2005. Mr. Hannon’s background includes the practice of corporate and transactional law, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements and corporate governance matters, with the law firms of Brobeck Phleger & Harrison LLP and Heller Ehrman LLP. Mr. Hannon received a B.A. from the University of California, Berkeley, and a J.D. from Stanford Law School.

Carol Cox, Executive Vice President, External Affairs and Corporate Marketing

Carol Cox

Executive Vice President, External Affairs and Corporate Marketing

Carol Cox joined NuVasive in July 2014 and serves as our Executive Vice President, External Affairs and Corporate Marketing. In this role, Ms. Cox is responsible for leading NuVasive’s external communications efforts, which are inclusive of investor and public relations and government affairs, as well as corporate marketing and the NuVasive Spine Foundation. Ms. Cox has more than 20 years of senior level experience in cross-functional corporate roles in the healthcare sector. Ms. Cox joined NuVasive from Sanford-Burnham Medical Research Institute (Sanford-Burnham) where she served as Senior Vice President, External Affairs, leading external and internal communications, philanthropy, marketing, government relations and efforts to elevate the Institute’s global recognition. Prior to Sanford- Burnham, she served as Senior Vice President of External Affairs and Corporate Communications at Life Technologies, where she spearheaded global strategies to drive awareness of the company’s major initiatives, enhance its global brand, and maintain its corporate reputation across multiple stakeholder groups including shareholders, the media, government officials, customers and the communities. Before joining Life Technologies, Ms. Cox was Vice President of Investor Relations at CareFusion Corporation and Senior Vice President for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals, where her team received multiple awards from Institutional Investor magazine for outstanding performance. She holds a bachelor’s of arts degree in Foreign Affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.

Pete Leddy, Ph.D., Executive Vice President, Human Resources & Corporate Integrity

Pete Leddy, Ph.D.

Executive Vice President, Human Resources & Corporate Integrity

Pete Leddy, Ph.D., has served as our Executive Vice President, Human Resources & Corporate Integrity since July 2015 and is responsible for leadership of the NuVasive’s Human Resources, Compliance, Regulatory and Facilities departments after serving as a member of the Company’s Board of Directors from 2011 to July 2015.  Dr. Leddy’s success in driving business growth through the application of best-in-class, innovative Human Resource solutions has resulted in his leading several major employee and cultural transformation initiatives throughout his more than 25 year career. Most recently, he served as Chief Human Resource Officer at Taylor Made Golf Company.  From 2005 to February 2014, Dr. Leddy served as Chief Human Resources Officer at Life Technologies, a biotechnology company. During his tenure at Life Technologies, Dr. Leddy developed a premier human resources function, aligning business strategy to business growth for 10,000 employees at over 80 sites worldwide.  Prior to Life Technologies, Dr. Leddy held several senior management positions with Dell Incorporated, from 2000 to 2005, where he was responsible for leading global talent and human resources in the Americas, overseeing 12,000 employees.  He has served as the Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites), implementing human resources strategies that drove operational excellence with 350 HR professionals in every level of the company. In addition, he has held a variety of executive and human resource positions at PepsiCo.  Dr. Leddy currently serves on the board of directors of Pathway Genomics Corporation. He received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.

Johnson Lai , Chief Information Officer

Johnson Lai

Chief Information Officer

Johnson Lai has served as our Chief Information Officer since August 2015.  Mr. Lai has more than 20 years of IT leadership experience and brings to the role extensive expertise in advancement of enterprise IT initiatives.  Most recently, he was Vice President of IT at Thermo Fisher Scientific where he was responsible for providing the IT leadership to the Laboratory Products business group, as well as being an executive member of the integration management team that governed the integration of Life Technologies into Thermo Fisher Scientific.  In that capacity, Mr. Lai was responsible for driving processes that created a combined IT vision and successfully executing global programs that achieved the targeted revenue and cost synergy objectives.  Additionally, he provided IT leadership for Thermo Fisher Scientific’s corporate functions with a business centric approach, including the support of mergers and acquisitions, among other responsibilities.  Previously, as a senior IT leader at Life Technologies, Mr. Lai was responsible for delivering critical IT projects, including a global ERP, e-commerce and IT integration of companies acquired.  Prior to that, Mr. Lai was a global IT leader for Abbott Vascular where he led the deployment of a single instance global ERP system and further matured the IT infrastructure and data centers to world-class levels.  Mr. Lai has a Bachelor of Science in Managerial Economics from the University of California at Davis and a Master of Business Administration with an emphasis in MIS, Accounting & Finance from the University of California at Davis.

Jason D. Hanson, Executive Vice President, Strategy, Corporate Development and General Counsel

Jason D. Hanson

Executive Vice President, Strategy, Corporate Development and General Counsel

Jason D. Hanson has served as our Executive Vice President, Strategy, Corporate Development and General Counsel since November 2015 and is responsible for leading NuVasive’s corporate development and mergers and acquisitions strategy, in addition to all legal matters pertaining to the Company, including corporate and strategic transactions, litigation and risk management, among other business matters.  Mr. Hanson previously served as Corporate Vice President, Chief Risk Officer and Vice President, General Counsel of GE Healthcare since May 2014 where he had global business responsibility for legal, compliance, government relations, enterprise risk management and various key corporate development activities.  Prior to joining GE Healthcare, he served as Company Group Chairman and Executive Vice President at Valeant Pharmaceuticals from 2012 to 2013 with responsibility for the Consumer, Ophthalmology, Latin American and Dental businesses, as well as the manufacturing and supply chain, R&D, regulatory and medical affairs teams.  Mr. Hanson previously spent seven years at Medicis Pharmaceutical Corporation where he served as Executive Vice President and Chief Operating Officer since 2010.  He joined Medicis in 2006 and was appointed to the position of Executive Vice President, General Counsel and Corporate Secretary.  Between 2004 and 2006, Mr. Hanson served as General Counsel for GE Healthcare Technologies where he was responsible for global legal affairs, and from 2001 to 2004 he was General Counsel for the Americas region at GE Medical Systems.  Mr. Hanson first joined GE in 1999 serving as Senior Counsel for Litigation and Compliance for GE Medical Systems.  He began his career with Arnold & Porter in Washington, D.C. and then went on to serve with the United States Department of Justice, Antitrust Division in Washington D.C. as a prosecutor and trial attorney.  Mr. Hanson earned his law degree at Duke University, where he was an editor of the law review, and earned his undergraduate degree in Economics from Cornell University.

Ed Roschak, CEO of NuVasive Specialized Orthopedics™, Inc.

Ed Roschak

CEO of NuVasive Specialized Orthopedics™, Inc.

Ed Roschak has served as our CEO of NuVasive Specialized Orthopedics, Inc. since February 2016.  Previously, he served as President and Chief Executive Officer, and as a member of the board of directors, of Ellipse Technologies, Inc. from September 2011 until NuVasive’s acquisition of Ellipse in February 2016.  From October 2010 to September 2011, Mr. Roschak served as Ellipse’s Chief Operating Officer.  Prior to Ellipse, Mr. Roschak was employed for nearly ten years by Broncus Technologies, Inc.,  medical device company focused on developing devices for the treatment of lung diseases, including serving as their Senior Vice President of Research and Development from January 2007 to February 2010.  During his time there, Broncus completed the spin-off of Asthmatx, a less-invasive catheter-based bronchial thermoplasty medical device company which was later acquired by Boston Scientific.  Prior to Broncus, Mr. Roschak served in several positions at Hewlett-Packard and Guidant following the acquisition of Origin Medsystems.  Mr. Roschak received a B.S. in mechanical engineering from the University of California, Santa Barbara and an M.B.A. from the University of Oregon.